AbbVie Total Liabilities

AbbVie (ABBV.BA) currently reports a total liabilities of $140B as of June 2026. That compares with $140B in the prior-year period — up 2.7% year over year. Use the charts on this page to explore AbbVie's total liabilities history and peer comparisons.

AbbVie's total liabilities increased from $140B to $140B — a 2.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AbbVie reported $140B in total liabilities as of June 2026. That compares with $140B in the prior-year period — up 2.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $140B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AbbVie, and consider following ABBV.BA for alerts when major investors trade the stock.

AbbVie is classified in the Healthcare sector. On total liabilities, it currently shows $140B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABBV.BA with unrelated industries.